chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got DVT within one week after receiving the Covid Booster vaccine, which FNP-C felt was highly suspicious.
The patient received less than recommended dose of MMR II vaccine because the patient moved during the administration/The patient received only about 40% of the total dose; No AE; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided.  On an unknown date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin [rHA]) (M-M-R II) subcutaneous injection (lot# W011885 has been verified to be a valid lot number and expiration date was 04-SEP-2023; strength, dose, and route were not provided) for prophylaxis with sterile diluent, solution for injection/infusion (lot #U033553 has been verified to be a valid lot number and expiration date was 07-MAY-2024; strength, dose, and route were not provided).  It was reported that the patient received less than recommended dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) vaccine because the patient moved during the administration. The patient received only about 40% of the total dose (Accidental underdose). No adverse event was reported. The outcome of the event was unknown.
Pt contacted urgent care on 8/8 c/o severe on b/l upper extremity (from shoulders to elbow) and behind both knees. 3/10 pain at injection site. At telephone appointment on 8/9, pt indicated that there was no lip swelling, tongue swelling or SOB. No fever or chills. No wheezing. No skin breakdown or discharge. He was taking benadryl and applying topical cortisone cream but it was not helping.   Pt was prescribed loratadine 10mg PO Daily x7 days and Prednisone 20mg PO daily  x5days.  In person visit on 8/11, pt c/o medications not helping but UC provider indicates that no rash can be found besides "pimples".  Pt was prescribed triamcinolone 0.1% cream Applied to affected area BID and hydroxyzine 25mg PO QID. PMH: HTN, Asthma, Obesity, OSA, GERD, Spondyloarthritis, ankylosing spondylitis, Hx of H. Pylori Pt had a respiratory illness concerning for COVID in early July after travel in late June.  Tested Negative for COVID 7/8/21 Medications at time of vaccination: Losartan 50mg PO Daily
Patient received 1st dose of Moderna COVID vaccine on 04/12/21. Patient presented to Pharmacy to receive the 2nd dose of Moderna COVID vaccine on 05/13/21 but was inadvertently given the Janssen vaccine. The CDC was contacted and it was determined that patients that inadvertently receive the wrong 2nd dose of the COVID vaccine and still considered to be fully vaccinated and no additional action is needed on the part of the patient. The patient's immunization record has been updated to document the actual vaccine given.
excruciating headache front and back of head, fever 102.4, body aches, fatigue, weakness, nausea, inability to focus
After the vaccination he threw up and had sore arm and at night the whole body was aching. A couple of days later he went to the hospital and the doctors said his arteries are ruptured and they ran a couple of tests but couldn't find anything wrong. The blood pressure was really bad and they kept him 3 days and two days later he dropped again and we went to the emergency again and they ran a couple of tests and found out he was bleeding internal his blood cell count was really low and that's when they did a treatment on him.
Pt seen in office evening of 8/25/15. Worsened. Seen in ER later that night and diagnosed with intussusception. Air enema x 2 - not resolved. Surgery done to reverse problem.
Arm soreness that started 8 hours after vaccination and lasted around 80 hours total. Low fever of 99.2 that started the following day and only lasted 24 hours. Headache that started the next day and lasted around 48 hours. Swollen lymph node by left collarbone that started the following day and has lasted 4 days after vaccine. Soreness and irritation in right eye that started 24 hours after vaccination.
Chills, sore muscles, sore throat, cough, runny nose, always feeling cold and tired now.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 26-Jul-2022).    No concomitant product use was reported.  Reportedly, Patient received half dose.  Date the vial was initially stored in the refrigerator was 04-Jun-2022.    Vial did not undergone any temperature excursions.  No treatment information was provided.
I have completed your on-line reporting form.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT. At the time of the report, ADVERSE EVENT outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
rash on the injection site; red itchy and expanding; red itchy and expanding; it hurts when touched; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on the injection site), RASH ERYTHEMATOUS (red itchy and expanding), RASH PRURITIC (red itchy and expanding) and PAIN (it hurts when touched) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE RASH (rash on the injection site), RASH ERYTHEMATOUS (red itchy and expanding), RASH PRURITIC (red itchy and expanding) and PAIN (it hurts when touched). At the time of the report, VACCINATION SITE RASH (rash on the injection site), RASH ERYTHEMATOUS (red itchy and expanding), RASH PRURITIC (red itchy and expanding) and PAIN (it hurts when touched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not provided. the Treatment information was not given.
Fluctuating oxygen levels; Violent vomiting; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting). At the time of the report, OXYGEN SATURATION ABNORMAL (Fluctuating oxygen levels) and VOMITING (Violent vomiting) outcome was unknown. Not Provided          No concomitant medication provided. No treatment information provided.
Persistent dry throat , feeling  the need to clear my throat but little to no phlegm is produced.     Night sweats, difficulty regulating body temperature (Example: Feeling the need for air conditioning but feel cold after  shortly after)  I  normally work outdoors (over 30 yrs)   and some of these symptoms are close to seasonal allergies but this has been a constant since over 30 days since 2nd vaccine shot
Ill; Body aches; Extreme fatigue; Headaches; Low grade fever; This case was reported by a consumer via call center representative and described the occurrence of unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th September 2019, the patient received the 2nd dose of Shingrix. On 6th September 2019, 1 days after receiving Shingrix, the patient experienced unwell. In September 2019, the patient experienced general body pain, fatigue, headache and low grade fever. On an unknown date, the outcome of the unwell, general body pain, fatigue, headache and low grade fever were recovering/resolving.   It was unknown if the reporter considered the unwell, general body pain, fatigue, headache and low grade fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was ill and less than a week after vaccination experienced body aches, extreme fatigue, headaches and low grade fever. The patient asked whether is this normal for the 2nd dose. This case has been linked with case US2019AMR163558, reported by the same reporter.
9/17 - 4pm flu shot (High Dose) -> 7 pm felt bad -> 12 AM fever 101.9 (ADVIL). 9/18 - 2 am fever > 102 (TYLENOL & fluids) & headache. 9/18 - continued fever, headache, fatigue - took antipyretics all day - pushed fluids, decreased solid food. 9/19-9/20 - fatigue, low grade fever - slept, antipyretics. 9/21 - nasal cong, cough? R/T post nasal drip - 9/22 - Productive deep cough 9/23 - today still feels bad but improving. May see primary provider today.
Patient has been covid free, but has developed tinnitus that has last close to a month at this point.
Freezing, fever, headache, joint pain in hands and wrists, terrible body aches,  fatigue, inability to sleep.  Treated with Tylenol.  I'm on day 2 and still suffering
while taking blood pressure patient passed out; not feel well; fever; aches; headache; chills; A spontaneous report was received from a nurse concerning a 66-year old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, aches, headache, chills, did not feel well and passed out.  The patient's medical history included atrial fibrillation following symptoms of feeling sick, headache and chest discomfort in September 2020. Current conditions included elevated blood pressure (BP) and a shrimp/shellfish allergy. Concomitant medications included apixaban, carvedilol, lisinopril and vitamin D.  On 04 Feb 2021, the patient received the first of two planned doses of mRNA-1273 (Batch Number: 013M20A) intramuscularly in left arm for prophylaxis of COVID-19 infection. On 05 Feb 2021, one day after receiving the vaccine, the patient experienced fever, aches, headache and chills. She took paracetamol and felt better. On that same day at approximately 1330, 24 hours after the vaccine, the patient was preparing a sandwich and was not feeling well. She sat in a chair to take her blood pressure and passed out.  At some point, it was reported that patient was admitted to the hospital for a five-day stay.  (admission/discharge dates not reported).  Treatment for the events included paracetamol.  There was not change planned to the dosing schedule of mRNA-1273 in response to the events as it is known that on 05 Mar 2021, the patient received the second of two planned doses of mRNA-1273 (Batch Number: 002A21A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  The outcome of the events, fever, aches, headache, chills, not feel well and passed out,  was considered recovered/resolved on an unspecified date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Symptons:  swollen face, lips, eyes, lymph nodes, rash on face, bad itching on face, extremely dry face and lips  Treatment: steroid shot and steroid pack and Benadryl tabs as needed for itchy
extreme fatigue; MUSCLE PAIN ON THE SIDE WHERE VACCINE WAS GIVEN; muscle pain on the side where vaccine was given; Vomiting; Fever; Chills; Hot and Cold influx; RIGHT ARM WENT NUMB ABOUT AN HOUR AFTER VACCINE; Hot and Cold influx; This is a spontaneous report from a contactable Other-HCP (patient).   A 36-Year-old (non-pregnant) female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3248) via an intramuscular route of administration at left arm on 03Feb2021 at 08:00 AM (at the age of 36-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history included known allergies with sulfa, morphine, latex, (lamotrigine) LAMICTAL. The patient's concomitant medications were not reported. Past drug included morphine and (lamotrigine) LAMICTAL. On 03Feb2021 at 15:00, the patient experienced extreme fatigue, muscle pain on the side where vaccine was given, vomiting, fever, chills, hot and cold influx, right arm went numb about an hour after vaccine. The patient received (ondansetron) ZOFRAN and ibuprofen to treat the adverse events. The patient did not receive any other vaccine prior COVID vaccination. The patient COVID test was unknown post vaccination. It was reported that the patient was recovered with lasting effects. The outcome of the events was recovered with sequel on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Patient's reaction(s) noted during COVID vaccine observation period:  0754, patient complaints of feeling itchy and reddness at injection site, runny nose.  No hives noted.   0754: 126/67, 98% O2, 77 HR 0805: 118/66, 98% O2, 75 HR; still c/o itchiness and redness at injection site, post-nasal drip 0820: Pt stated that she is feeling itchy in mouth and is having thicker post-nasal drip.  Code Medic called and at bedside within a minute. Taken via wheelchair to ED and pt remained awake and alert.   Patient reports previous anaphylactic reaction after receiving the flu shot. Discharged home from ED 1000
The injection site alone with the upper arm is red, hot, and warm to touch. I marked the original spot on Friday and it has since went pass that point. It does hurt pretty bad but I have not been babying it but using it as normal. More achy than pain I would say.
Information has been received from a health professional concerning a 39-year-old female employee, with no medical history and no allergies, who on 17-AUG-2006 was vaccinated with a 0.5 ml subcutaneous dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (Lot#652483/0148F).  There was no concomitant medication.  On 06-SEP-2006 the patient experienced cellulitis at the injection site that required her to be hospitalized for two days.  The patient was treated with IV antibiotics and released.  No product quality complaint was involved.  No other information was provided.  The reporter considered the patient's reaction to be an other important medical event.  Additional information has been requested. (OMIC)
SEVERE SOAR THROAT, COUGHING, FATIGUE, WHEEZING AT BED TIME & DRY COUGH. THIS CONTINUED FOR 3 WEEKS. TOOK OTC COUGH SYRUP. INTO SECOND WEEK FELT LIKE BRONCHITIS.
Arm was swollen at and around injection site.  Son said it was itchy and there was a red rash 2 inches in diameter around the injection site.
Symptoms started early morning hours following the shot, chills, extreme body aches, extreme headaches, fatigue to the point that it was difficult to get out of bed. The skin on certain areas of my body are very sensitive and have a tingling sensation.
Patient with type 2 diabetes reported as "uncontrolled" was vaccinated with Zostavax; Information has been received from the authors in the published literature article entitled as stated below, referring to an 83-year-old male patient with type 2 diabetes reported as "uncontrolled" (A1C hemoglobin result of 10.9 (units not provided)). According to the authors, this patient's condition was considered as an immunocompromised state.  On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) subcutaneous injection, administered for prophylaxis (lot #, expiry date, route of administration, and anatomical location were not provided) (contraindicated product administered).  A copy of the published article is attached as further documentation of the patient's experience.  Literature report.
Hair is falling out; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient received BNT162b2 (BNT162B2), on 07Apr2022 as dose 4 (booster), single (Lot number: FV4989) at the age of 76 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: ER8730; Anatomical location: left arm), administration date: 27Mar2021, when the patient was 75-year-old, for COVID-19 immunization, reaction(s): "Hair is falling out"; BNT162b2 (DOSE 2, SINGLE; Lot number: EW0151; Exp Date: 31Mar2021; Anatomical location: left arm), administration date: 13Apr2021, when the patient was 75-year-old, for COVID-19 immunization, reaction(s): "Hair is falling out"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: FB509; Anatomical location: left arm), administration date: 10Oct2021, when the patient was 76-year-old, for COVID-19 immunization, reaction(s): "Hair is falling out". The following information was reported: ALOPECIA (non-serious), outcome "not recovered", described as "Hair is falling out".  Additional information: The patient did not had any other conditions. The patient has had all of the shots and everything, even the last one she had. Since she started getting vaccines the patient had noticed her hair was falling out. She started to do research and back tracking everything and noticed it was the vaccine. The patient wanted to know if anything she can do to prevent losing all her hair. The patient always had thick hair and now all of a sudden it was extremely thin. Several months later noticed hair was falling out, like noticed it 6 to 8 months after getting the vaccine. Her drain was full of hair and never had that. The patient was given a blood pressure medicine around this time by her doctor. The patient thought at first it was the blood pressure medicine. However, she stopped the medicine and her hair would continue to fall out and she realized it was not the blood pressure medicine. She confirmed she does not remember the name of the blood pressure medicine. The adverse event did not resulted in Physician Office or Emergency Room visit. The patient did not undergo any relevant lab tests.
Arm pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Arm pain). The outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     It was unknown if the company considered the pain in arm to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR039031   Additional Information: GSK Receipt Date: 13-MAR-2023 The reporter was patient. The patient experienced arm pain after the 1st dose of Shingrix. The patient got the Shingrix booster after 2 months on the day of reporting at 10:30 am and did not have any side-effects.  The patient asked if it was normal. The follow-up could not be possible as no contact details were available; Sender's Comments:  US-GSK-US2023AMR039031:Same reporter
Over 2 week hx of significant "feels like knives are stabbing" in arm where vaccine given and to acromion region as well- still present currently.
Shingles in L2 distribution on left side. Started with skin sensitivity and inguinal lymphadenopathy 1-2 days prior to emergence of characteristic lesions on left side of back in L2 distribution